https://european-biotechnology.com/latest-news/ventuno-biotech-secures-euro-3m/
Ventuno Biotech Secures €3m to Power Next-Gen Cancer Immunotherapies - European Biotechnology...
Nov 27, 2025 - Lyon-based Ventuno Biotech secures fresh backing to accelerate its preclinical pipeline of first-in-class immuno-oncology assets.
power next genbiotech secures
https://www.streetwisereports.com/article/2025/10/01/biotech-secures-fda-alignment-on-late-stage-duchenne-therapy.html?m_t=2025_10_01_07_27_12
Biotech Secures FDA Alignment on Late-Stage Duchenne Therapy
Capricor Therapeutics Inc. (CAPR:NASDAQ) reached agreement with the FDA to include HOPE-3 trial data in its BLA for Deramiocel, its cell therapy for Duchenne...
late stage duchennebiotechfda
https://www.business-live.co.uk/technology/biotech-firm-invenirex-secures-2m-32897899
Biotech firm InvenireX secures £2m investment to accelerate medical advances - Business Live
The Newcastle University spin-out will use the funding to grow its team and expand its operations
biotech firmmedical advances